OKYO Pharma Limited
OKYO · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,561 | $827 | $4,045 | $2,701 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1,889 | $581 | $980 | $883 |
| Inventory | $0 | $0 | $170 | -$1 |
| Other Curr. Assets | $225 | $130 | $1 | $713 |
| Total Curr. Assets | $3,675 | $1,538 | $5,197 | $4,295 |
| Property Plant & Equip (Net) | $2 | $3 | $7 | $5 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2 | $3 | $7 | $5 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,677 | $1,541 | $5,204 | $4,301 |
| Liabilities | – | – | – | – |
| Payables | $7,900 | $6,128 | $1,024 | $518 |
| Short-Term Debt | $0 | $0 | $2,215 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,327 | $1,293 | $4,018 | $836 |
| Total Curr. Liab. | $9,227 | $7,421 | $7,257 | $1,353 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $9,227 | $7,421 | $7,257 | $1,353 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $146,717 | $143,113 | $0 | $123,977 |
| Retained Earnings | -$143,025 | -$142,523 | -$125,698 | -$112,426 |
| AOCI | -$11,470 | -$11,311 | -$7,741 | -$11,012 |
| Other Equity | $146,716 | $4,842 | $131,385 | $2,408 |
| Total Equity | -$5,550 | -$5,880 | -$2,053 | $2,947 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,677 | $1,541 | $5,204 | $4,301 |
| Net Debt | -$1,561 | -$827 | -$1,830 | -$2,701 |